Alan Šerman

453 total citations
27 papers, 324 citations indexed

About

Alan Šerman is a scholar working on Molecular Biology, Obstetrics and Gynecology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Alan Šerman has authored 27 papers receiving a total of 324 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 10 papers in Obstetrics and Gynecology and 4 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Alan Šerman's work include Pregnancy and preeclampsia studies (10 papers), Epigenetics and DNA Methylation (8 papers) and Wnt/β-catenin signaling in development and cancer (5 papers). Alan Šerman is often cited by papers focused on Pregnancy and preeclampsia studies (10 papers), Epigenetics and DNA Methylation (8 papers) and Wnt/β-catenin signaling in development and cancer (5 papers). Alan Šerman collaborates with scholars based in Croatia, Qatar and Bosnia and Herzegovina. Alan Šerman's co-authors include Ljiljana Šerman, Maja Vlahović, Floriana Bulić‐Jakuš, Semir Vranić, Dominique Weil, François Dautry, Michel Kress, Florence Le Roy, Tamara Nikuševa Martić and Christelle Aigueperse and has published in prestigious journals such as Nucleic Acids Research, SHILAP Revista de lepidopterología and Cells.

In The Last Decade

Alan Šerman

26 papers receiving 316 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alan Šerman Croatia 9 218 91 77 37 34 27 324
Bryan Marsh United States 6 126 0.6× 54 0.6× 84 1.1× 31 0.8× 53 1.6× 6 236
Yanxing Wei China 13 169 0.8× 84 0.9× 142 1.8× 35 0.9× 88 2.6× 23 351
Yuqi Yang China 9 138 0.6× 150 1.6× 125 1.6× 21 0.6× 64 1.9× 32 367
Marta Guindo-Martínez Spain 7 125 0.6× 63 0.7× 62 0.8× 93 2.5× 20 0.6× 9 253
Patrizia Doi Italy 10 120 0.6× 103 1.1× 158 2.1× 44 1.2× 38 1.1× 17 349
Mariyan J. Jeyarajah Canada 9 116 0.5× 110 1.2× 180 2.3× 26 0.7× 77 2.3× 12 288
Richard Casselman Canada 11 310 1.4× 95 1.0× 133 1.7× 83 2.2× 67 2.0× 12 455
Matthew Sagnelli China 10 87 0.4× 131 1.4× 93 1.2× 64 1.7× 22 0.6× 15 271
Xunqiang Yin China 9 126 0.6× 129 1.4× 63 0.8× 95 2.6× 74 2.2× 16 362

Countries citing papers authored by Alan Šerman

Since Specialization
Citations

This map shows the geographic impact of Alan Šerman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Šerman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Šerman more than expected).

Fields of papers citing papers by Alan Šerman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan Šerman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Šerman. The network helps show where Alan Šerman may publish in the future.

Co-authorship network of co-authors of Alan Šerman

This figure shows the co-authorship network connecting the top 25 collaborators of Alan Šerman. A scholar is included among the top collaborators of Alan Šerman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan Šerman. Alan Šerman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Karin‐Kujundžić, Valentina, et al.. (2025). Hedgehog signalling pathway inhibitors in the treatment of basal cell carcinoma: an updated review. Journal of drug targeting. 33(8). 1322–1342. 1 indexed citations
2.
Šerman, Alan, et al.. (2024). Does ChatGPT-4 succeed in the ECG interpretation: friend or foe to cardiologists?. EP Europace. 26(Supplement_1). 2 indexed citations
3.
Šerman, Alan, Valentina Karin‐Kujundžić, Frane Paić, et al.. (2020). Dishevelled family proteins (DVL1-3) expression in IUGR placentas. Bosnian Journal of Basic Medical Sciences. 21(4). 447–453. 1 indexed citations
4.
Šerman, Alan, et al.. (2020). The role of glycogen synthase kinase 3 (GSK3) in cancer with emphasis on ovarian cancer development and progression: A comprehensive review. Bosnian Journal of Basic Medical Sciences. 21(1). 5–18. 19 indexed citations
5.
Bulić‐Jakuš, Floriana, et al.. (2019). Sustainable development for the Mediterranean. 13–39. 2 indexed citations
6.
Šeparović, Robert, et al.. (2018). CANCER PATIENTS FOLLOW-UP – CROATIAN SOCIETY OF MEDICAL ONCOLOGY CLINICAL GUIDELINES Part I: breast cancer, uterine cancer, cervical cancer, ovarian cancer.. PubMed. 138(3-4). 167–72. 1 indexed citations
7.
Karin‐Kujundžić, Valentina, Anita Škrtić, Alan Šerman, et al.. (2017). Negative regulators of Wnt signaling pathway SFRP1 and SFRP3 expression in preterm and term pathologic placentas. The Journal of Maternal-Fetal & Neonatal Medicine. 31(22). 2971–2979. 8 indexed citations
8.
Škrtić, Anita, et al.. (2016). ELF5 transcription factor expression during gestation in humans and rats – an immunohistochemical analysis. The Journal of Maternal-Fetal & Neonatal Medicine. 30(11). 1261–1266. 2 indexed citations
9.
Šerman, Ljiljana, et al.. (2015). Structural changes in the rat placenta during the last third of gestation discovered by stereology. SHILAP Revista de lepidopterología. 15(1). 21–25. 10 indexed citations
10.
Šerman, Ljiljana, Tamara Nikuševa Martić, Alan Šerman, & Semir Vranić. (2014). Epigenetic alterations of the Wnt signaling pathway in cancer: a mini review. SHILAP Revista de lepidopterología. 14(4). 191–194. 38 indexed citations
11.
Martić, Tamara Nikuševa, et al.. (2014). Glycosylation pattern and axin expression in normal and IUGR placentae. The Journal of Maternal-Fetal & Neonatal Medicine. 28(5). 558–563. 4 indexed citations
12.
Šerman, Alan, et al.. (2012). Epigenetic control of cell invasion – the trophoblast model. BioMolecular Concepts. 3(6). 487–494. 5 indexed citations
13.
Šerman, Ljiljana, et al.. (2010). An in vivo rat model to study epigenetic control of cell invasion. Medical Hypotheses. 76(3). 407–409. 4 indexed citations
15.
Šerman, Ljiljana, Nino Sinčić, Alan Šerman, et al.. (2008). Changes of Membrane Proteins Expression in Rat Placenta Treated with 5-Azacytidine. Tierärztliche Umschau. 63(7). 391. 1 indexed citations
16.
Šerman, Alan, Florence Le Roy, Christelle Aigueperse, et al.. (2007). GW body disassembly triggered by siRNAs independently of their silencing activity. Nucleic Acids Research. 35(14). 4715–4727. 68 indexed citations
17.
Šerman, Ljiljana, Maja Vlahović, Floriana Bulić‐Jakuš, et al.. (2007). The Impact of 5-Azacytidine on Placental Weight, Glycoprotein Pattern and Proliferating Cell Nuclear Antigen Expression in Rat Placenta. Placenta. 28(8-9). 803–811. 70 indexed citations
18.
Šerman, Ljiljana & Alan Šerman. (2006). ULOGA GLIKOPROTEINA U PROCESIMA IMPLANTACIJE I PLACENTACIJE. University of Zagreb University Computing Centre (SRCE). 15(2). 82–88. 1 indexed citations
19.
Šerman, Ljiljana & Alan Šerman. (2006). The role of glycoproteins in the processes of implantation and placentation. 15(2). 82–88. 1 indexed citations
20.
Šerman, Ljiljana, et al.. (2004). Comparison of glycosylation patterns of placental proteins between normal pregnancy and missed abortion.. PubMed. 28(1). 301–8. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026